- Home
- NEGG vs ENGN Comparison
NEGG vs ENGN Comparison
Compare NEGG & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEGG | ENGN |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 379.3M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEGG | ENGN |
|---|---|---|
| Price | $52.43 | $9.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $22.71 |
| AVG Volume (30 Days) | 135.1K | ★ 280.3K |
| Earning Date | 12-01-2025 | 12-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,313,127,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.32 | $2.65 |
| 52 Week High | $137.84 | $11.14 |
Technical Indicators
Market Signals| Indicator | NEGG | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 35.90 | 64.36 |
| Support Level | $53.32 | $7.57 |
| Resistance Level | $59.21 | $10.10 |
| Average True Range (ATR) | 4.84 | 0.73 |
| MACD | -1.24 | 0.11 |
| Stochastic Oscillator | 2.38 | 75.89 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.